Literature DB >> 104057

Chromium deficiency during total parenteral nutrition.

H Freund, S Atamian, J E Fischer.   

Abstract

Chromium is required for maintenance of normal glucose tolerance. After complete bowel resection and five months of total parenteral nutrition, severe glucose intolerance, weight loss, and a metabolic encephalopathy-like confusional state developed in a patient. Serum chromium levels were at the lowest normal level. Supplementation of 150 microgram of chromium per day reversed the glucose intolerance, reduced insulin requirements, and resulted in weight gain and the disappearance of encephalopathy. The low levels of chromium and response to chromium supplementation suggest that chromium deficiency can arise in long-term total parenteral nutrition.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 104057

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  26 in total

Review 1.  Molecular mechanisms of chromium in alleviating insulin resistance.

Authors:  Yinan Hua; Suzanne Clark; Jun Ren; Nair Sreejayan
Journal:  J Nutr Biochem       Date:  2012-04       Impact factor: 6.048

2.  Chromium deficiency after long-term total parenteral nutrition.

Authors:  R O Brown; S Forloines-Lynn; R E Cross; W D Heizer
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

3.  Elevated serum chromium in patients on total parenteral nutrition and the ionic species of contaminant chromium.

Authors:  F Y Leung; L V Galbraith
Journal:  Biol Trace Elem Res       Date:  1995-12       Impact factor: 3.738

Review 4.  Parenteral nutrition: current status and concepts.

Authors:  G D Phillips; C L Odgers
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

Review 5.  Zinc and chromium in parenteral nutrition.

Authors:  K N Jeejeebhoy
Journal:  Bull N Y Acad Med       Date:  1984-03

Review 6.  Current concepts about chromium supplementation in type 2 diabetes and insulin resistance.

Authors:  Zhong Q Wang; William T Cefalu
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

Review 7.  Chromium does not belong in the diabetes treatment arsenal: Current evidence and future perspectives.

Authors:  Gijs Wd Landman; Henk Jg Bilo; Sebastiaan T Houweling; Nanne Kleefstra
Journal:  World J Diabetes       Date:  2014-04-15

8.  Polyneuropathy in critically ill patients.

Authors:  C F Bolton; J J Gilbert; A F Hahn; W J Sibbald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

Review 9.  Chromium, glucose tolerance, and diabetes.

Authors:  R A Anderson
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

10.  Chromium status of full-term and preterm newborns.

Authors:  D Bougle; F Bureau; J Voirin; D Neuville; M Drosdowsky; J F Duhamel
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.